Connect with us

Health

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine – News-Medical.net

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha)…

Published

on

Article feature image

The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientific community and pharmaceutical industry to focus on the development of vaccines to combat the health…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending